Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Astrocytes express aberrant immunoglobulins as putative gatekeeper of astrocytes to neuronal progenitor conversion.
Capuz A, Osien S, Karnoub MA, Aboulouard S, Laurent E, Coyaud E, Raffo-Romero A, Duhamel M, Bonnefond A, Derhourhi M, Trerotola M, El Yazidi-Belkoura I, Devos D, Zilkova M, Kobeissy F, Vanden Abeele F, Fournier I, Cizkova D, Rodet F, Salzet M. Capuz A, et al. Among authors: trerotola m. Cell Death Dis. 2023 Apr 4;14(4):237. doi: 10.1038/s41419-023-05737-9. Cell Death Dis. 2023. PMID: 37015912 Free PMC article.
Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome.
Capuz A, Osien S, Cardon T, Karnoub MA, Aboulouard S, Raffo-Romero A, Duhamel M, Cizkova D, Trerotola M, Devos D, Kobeissy F, Vanden Abeele F, Bonnefond A, Fournier I, Rodet F, Salzet M. Capuz A, et al. Among authors: trerotola m. Cell Death Dis. 2023 Aug 16;14(8):526. doi: 10.1038/s41419-023-06037-y. Cell Death Dis. 2023. PMID: 37587118 Free PMC article.
Correction: Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome.
Capuz A, Osien S, Cardon T, Karnoub MA, Aboulouard S, Raffo-Romero A, Duhamel M, Cizkova D, Trerotola M, Devos D, Kobeissy F, F VA, Bonnefond A, Fournier I, Rodet F, Salzet M. Capuz A, et al. Among authors: trerotola m. Cell Death Dis. 2023 Oct 13;14(10):677. doi: 10.1038/s41419-023-06143-x. Cell Death Dis. 2023. PMID: 37833264 Free PMC article. No abstract available.
Phylogenetic conservation of Trop-2 across species-rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks.
Guerra E, Trerotola M, Relli V, Lattanzio R, Boujnah K, Travali N, Moschella A, Todaro P, Pierdomenico L, Di Pietro R, Tinari N, Alberti S. Guerra E, et al. Among authors: trerotola m. Front Genet. 2024 Jan 5;14:1297367. doi: 10.3389/fgene.2023.1297367. eCollection 2023. Front Genet. 2024. PMID: 38250577 Free PMC article.
Targeting Trop-2 as a Cancer Driver.
Guerra E, Trerotola M, Alberti S. Guerra E, et al. Among authors: trerotola m. J Clin Oncol. 2023 Oct 10;41(29):4688-4692. doi: 10.1200/JCO.23.01207. Epub 2023 Aug 7. J Clin Oncol. 2023. PMID: 37549340 No abstract available.
Rescue of secretion of a rare-disease associated mis-folded mutant glycoprotein in UGGT1 knock-out mammalian cells.
Tax G, Guay KP, Soldà T, Hitchman CJ, Hill JC, Vasiljević S, Lia A, Modenutti CP, Straatman KR, Santino A, Molinari M, Zitzmann N, Hebert DN, Roversi P, Trerotola M. Tax G, et al. Among authors: trerotola m. bioRxiv [Preprint]. 2023 May 31:2023.05.30.542711. doi: 10.1101/2023.05.30.542711. bioRxiv. 2023. PMID: 37398215 Free PMC article. Updated. Preprint.
3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer Vulnerability.
Guerra E, Trerotola M, Relli V, Lattanzio R, Tripaldi R, Ceci M, Boujnah K, Pantalone L, Sacchetti A, Havas KM, Simeone P, Travali N, Querzoli P, Pedriali M, Roversi P, Iezzi M, Tinari N, Antolini L, Alberti S. Guerra E, et al. Among authors: trerotola m. Mol Cancer Ther. 2023 Jun 1;22(6):790-804. doi: 10.1158/1535-7163.MCT-22-0352. Mol Cancer Ther. 2023. PMID: 36921314
55 results